ID: ALA3361413
Chembl Id: CHEMBL3361413
PubChem CID: 136998789
Max Phase: Preclinical
Molecular Formula: C37H48N6O5
Molecular Weight: 656.83
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)(C)OC(=O)/N=C(\NC(=O)OC(C)(C)C)Nc1cccc(C(=O)NCC2(Nc3ccccc3)CCN(Cc3ccccc3)CC2)c1
Standard InChI: InChI=1S/C37H48N6O5/c1-35(2,3)47-33(45)40-32(41-34(46)48-36(4,5)6)39-30-19-13-16-28(24-30)31(44)38-26-37(42-29-17-11-8-12-18-29)20-22-43(23-21-37)25-27-14-9-7-10-15-27/h7-19,24,42H,20-23,25-26H2,1-6H3,(H,38,44)(H2,39,40,41,45,46)
Standard InChI Key: MFCNLNAJVNURNL-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 656.83 | Molecular Weight (Monoisotopic): 656.3686 | AlogP: 6.79 | #Rotatable Bonds: 8 |
| Polar Surface Area: 133.39 | Molecular Species: BASE | HBA: 7 | HBD: 4 |
| #RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 3 |
| CX Acidic pKa: 9.76 | CX Basic pKa: 8.60 | CX LogP: 5.57 | CX LogD: 4.53 |
| Aromatic Rings: 3 | Heavy Atoms: 48 | QED Weighted: 0.15 | Np Likeness Score: -0.87 |
| 1. Journigan VB, Mésangeau C, Vyas N, Eans SO, Cutler SJ, McLaughlin JP, Mollereau C, McCurdy CR.. (2014) Nonpeptide small molecule agonist and antagonist original leads for neuropeptide FF1 and FF2 receptors., 57 (21): [PMID:25268943] [10.1021/jm500989n] |
Source(1):
